VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
Go back to VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan| (NASDAQ: VRXA) | Delayed: 1.59 -0.01 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.60 | 52 Week High | $ | |||
| Open | $1.62 | 52 Week Low | $ | |||
| Day High | $1.65 | P/E | N/A | |||
| Day Low | $1.56 | EPS | $ | |||
| Volume | 189,249 | |||||

